Answers are grounded in this paper and cite their sources.
Pilot study assesses hypersensitivity reactions to Urografin in patients undergoing CT scans, indicating low severe reactions.
Background: Patients react to radiographic contrast media in diverse ways. Objectives: To assess hypersensitivity reactions to Urografin contrast media among patients booked for contrast-enhanced computed tomography scans in a tertiary hospital in Nigeria. Methods: A prospective, 30-minute observation of each of 30 patients who had administration of urografin 76% intravenously. They were observed from the point of administration to the end of the investigation. Observed clinical reactions were documented and results were presented in tables. Results: Out of thirty patients, six patients (20%) had nausea which is termed as mild reaction. Four of them (13.3%) vomited, a condition considered as moderate reaction. Twenty (66.7%) did not present with any reaction to contrast within the study time frame. Conclusion: Nausea and vomiting were reactions observed in the study. No severe hypersensitivity reaction among all the patients who participated in the study was recorded.
No takes yet. Share an insight, caveat, or question.
Ogenyi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: